| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | Salt |
| UNII: | AP4OF2M98B |
| Parent Compound: | EMIXUSTAT |
| InChI Key | BPZWRYOUJMDQSY-PKLMIRHRSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C16H26ClNO2 |
| Molecular Weight | 299.84 |
| AlogP | 3.03 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 2.0 |
| Number of Rotational Bond | 6.0 |
| Polar Surface Area | 55.48 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 19.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| INHIBITOR | Retinoid isomerohydrolase inhibitor | PubMed |
| Mesh Heading | Maximum Phase | Reference |
|---|---|---|
| Diabetic Retinopathy; Retinal Diseases | Phase 2 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL2107829 |
| EPA CompTox | DTXSID00150670 |
| FDA SRS | AP4OF2M98B |
| PubChem | 60162270 |
| SureChEMBL | SCHEMBL2206235 |